Loading…

Warnings, uncertainty, and clinical practice

Paediatric anaesthetists in the USA and around the world were surprised in December, 2016, when the US Food and Drug Administration (FDA) issued a Drug Safety Communication warning that exposure to anaesthetic and sedative drugs for more than 3 h may cause adverse effects on the developing brain in...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2017-06, Vol.389 (10085), p.2174-2176
Main Authors: Polaner, David M, Zuk, Jeannie, McCann, Mary Ellen, Davidson, Andrew
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Paediatric anaesthetists in the USA and around the world were surprised in December, 2016, when the US Food and Drug Administration (FDA) issued a Drug Safety Communication warning that exposure to anaesthetic and sedative drugs for more than 3 h may cause adverse effects on the developing brain in infants younger than 3 years and in the fetus during the third trimester.1,2 The data on which the public warning was based were well known to practitioners and academics, but release of the warning occurred without advance notice, resulting in considerable consternation among clinicians.3 Evidence from animal studies has accumulated in the past two decades that lengthy general anaesthesia or sedation, both with drugs interacting at the N-methyl-D-aspartate receptor and at the γ-aminobutyric-acid (GABA) A receptor, increased neuroapoptosis, altered synaptogenesis, and resulted in abnormal neurodevelopment and performance in many species, including non-human primates.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(17)31506-4